Notícias07/11/2022 Analysis of the Prevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Student Cohorts Reveals Low-Prevalence Types and a Decline in Binding Antibody Levels during the SARS-CoV-2 PandemicABSTRACTHuman adenoviruses (HAdVs) are important tools for vector development for applications such as immunization, oncolytic therapy, or gene therapy.... Repositório Covid-1905/11/2022 Protocol for characterizing the inhibition of SARS-CoV-2 infection by a protein of interest in cultured cellsSummaryHere, we present a protocol to characterize the antiviral ability of a protein of interest to SARS-CoV-2 infection in... Repositório Covid-19 04/11/2022 ABIFINA, Grupo FarmaBrasil e PróGenéricos enviam documento ao Ministério da EconomiaABIFINA, Grupo FarmaBrasil e PróGenéricos enviaram ao Ministério da Economia nesta sexta, 04, documento em que expressam preocupação a respeito... Acontece na ABIFINA 04/11/2022 Comissão Especial de Saúde do CNCP/MJSP realiza workshop 'Combate aos produtos ilegais'O que os órgãos públicos têm feito para mitigar os impactos negativos da pirataria de produtos veterinários, de higiene pessoal,... Acontece na ABIFINA04/11/2022 Blau Farmacêutica acelera agenda estratégica e encerra trimestre com crescimento de Receita Líquida de 13% e expansão de Margens vs. 3T21São Paulo, 03 de novembro de 2022 – No 3T22, a Blau Farmacêutica S.A (BLAU3), uma das principais indústrias farmacêuticas da América Latina,... Associado em foco04/11/2022 Toxicity assessment of SARS-CoV-2-derived peptides in combination with a mix of pollutants on zebrafish adults: A perspective study of behavioral, biometric, mutagenic, and biochemical toxicityAbstractThe dispersion of SARS-CoV-2 in aquatic environments via the discharge of domestic and hospital sewage has been confirmed in... Repositório Covid-1903/11/2022 Papel das entidades setoriais na democraciaA revista Química e Derivados publicou na edição de outubro o artigo “Papel das entidades setoriais na democracia”, do presidente... ABIFINA na mídia03/11/2022 Outlook of various diagnostics and nanodiagnostic techniques for COVID-19AbstractThe sudden outbreak of the coronavirus disease 2019 (COVID-19) pandemic has brought to the fore the existing threat of... Repositório Covid-1902/11/2022 Covid-19 Vaccine Protection among Children and Adolescents in QatarAbstractBACKGROUNDThe BNT162b2 vaccine against coronavirus disease 2019 (Covid-19) has been authorized for use in children 5 to 11... Repositório Covid-1902/11/2022 Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infectionAbstractOn December 22, 2021, the United States Food and Drug Administration approved the first main protease inhibitor, i.e., oral... Repositório Covid-1901/11/2022 Effect of Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Booster on Human Immunodeficiency Virus Reservoirs and Immune MarkersThe clinical outcomes of coronavirus diseases 2019 (COVID-19) in people with human immunodeficiency virus (PWH) are variable. Early data involving... Repositório Covid-1931/10/2022 Blau celebra contrato para aquisição do Laboratório Bergamo, do grupo Amgen – empresa relevante no segmento biotecnologiaA Blau Farmacêutica S.A (Blau3), uma das principais indústrias farmacêuticas da América Latina, focada na produção de medicamentos de alta... Associado em foco
07/11/2022 Analysis of the Prevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Student Cohorts Reveals Low-Prevalence Types and a Decline in Binding Antibody Levels during the SARS-CoV-2 PandemicABSTRACTHuman adenoviruses (HAdVs) are important tools for vector development for applications such as immunization, oncolytic therapy, or gene therapy.... Repositório Covid-19
05/11/2022 Protocol for characterizing the inhibition of SARS-CoV-2 infection by a protein of interest in cultured cellsSummaryHere, we present a protocol to characterize the antiviral ability of a protein of interest to SARS-CoV-2 infection in... Repositório Covid-19
04/11/2022 ABIFINA, Grupo FarmaBrasil e PróGenéricos enviam documento ao Ministério da EconomiaABIFINA, Grupo FarmaBrasil e PróGenéricos enviaram ao Ministério da Economia nesta sexta, 04, documento em que expressam preocupação a respeito... Acontece na ABIFINA
04/11/2022 Comissão Especial de Saúde do CNCP/MJSP realiza workshop 'Combate aos produtos ilegais'O que os órgãos públicos têm feito para mitigar os impactos negativos da pirataria de produtos veterinários, de higiene pessoal,... Acontece na ABIFINA
04/11/2022 Blau Farmacêutica acelera agenda estratégica e encerra trimestre com crescimento de Receita Líquida de 13% e expansão de Margens vs. 3T21São Paulo, 03 de novembro de 2022 – No 3T22, a Blau Farmacêutica S.A (BLAU3), uma das principais indústrias farmacêuticas da América Latina,... Associado em foco
04/11/2022 Toxicity assessment of SARS-CoV-2-derived peptides in combination with a mix of pollutants on zebrafish adults: A perspective study of behavioral, biometric, mutagenic, and biochemical toxicityAbstractThe dispersion of SARS-CoV-2 in aquatic environments via the discharge of domestic and hospital sewage has been confirmed in... Repositório Covid-19
03/11/2022 Papel das entidades setoriais na democraciaA revista Química e Derivados publicou na edição de outubro o artigo “Papel das entidades setoriais na democracia”, do presidente... ABIFINA na mídia
03/11/2022 Outlook of various diagnostics and nanodiagnostic techniques for COVID-19AbstractThe sudden outbreak of the coronavirus disease 2019 (COVID-19) pandemic has brought to the fore the existing threat of... Repositório Covid-19
02/11/2022 Covid-19 Vaccine Protection among Children and Adolescents in QatarAbstractBACKGROUNDThe BNT162b2 vaccine against coronavirus disease 2019 (Covid-19) has been authorized for use in children 5 to 11... Repositório Covid-19
02/11/2022 Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infectionAbstractOn December 22, 2021, the United States Food and Drug Administration approved the first main protease inhibitor, i.e., oral... Repositório Covid-19
01/11/2022 Effect of Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Booster on Human Immunodeficiency Virus Reservoirs and Immune MarkersThe clinical outcomes of coronavirus diseases 2019 (COVID-19) in people with human immunodeficiency virus (PWH) are variable. Early data involving... Repositório Covid-19
31/10/2022 Blau celebra contrato para aquisição do Laboratório Bergamo, do grupo Amgen – empresa relevante no segmento biotecnologiaA Blau Farmacêutica S.A (Blau3), uma das principais indústrias farmacêuticas da América Latina, focada na produção de medicamentos de alta... Associado em foco
